ICD G23.1ORPHA:683PSP

Progressive Supranuclear Palsy

Progressive Supranuclear Palsy is a rare brain disease that causes degeneration of cells in the brainstem and cerebral cortex. It is frequently misdiagnosed as Parkinson's disease. Key features include falls, eye movement abnormalities, stiffness, and cognitive changes. There is no disease-modifying treatment and median survival after diagnosis is 6-7 years.

463
Articles
143
Trials (1 AU)
Updated
5 April 2026
Loading...

Common Questions

What is Progressive Supranuclear Palsy?

Progressive Supranuclear Palsy is a rare brain disease that causes degeneration of cells in the brainstem and cerebral cortex. It is frequently misdiagnosed as Parkinson's disease. Key features include falls, eye movement abnormalities, stiffness, and cognitive changes. There is no disease-modifying treatment and median survival after diagnosis is 6-7 years.

How many clinical trials are available for Progressive Supranuclear Palsy?

RareWays currently indexes 143 clinical trials for Progressive Supranuclear Palsy, of which 30 are actively recruiting. Trial availability changes as new studies are registered — check the trials tab for current status.

Where does the research data for Progressive Supranuclear Palsy come from?

RareWays aggregates research from PubMed, Europe PMC, OpenAlex, and ClinicalTrials.gov. Data is updated regularly by Rocky, RareWays' automated research engine. All articles and trials link directly to their original sources.

Get research updates

Monthly email when new findings are published for Progressive Supranuclear Palsy.

No spam. Unsubscribe any time. Not medical advice.

This information is for general awareness only.

For guidance specific to your situation, please speak with your healthcare team.